A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

34-Hydroxy Sirolimus | CAS 185107-79-3 - Request Quote

Picture of 34-Hydroxy Sirolimus

34-Hydroxy Sirolimus

SZ CAT No:SZ-R025028
CAS No
185107-79-3
Mol.F.
C51H81NO14
Mol.Wt.
932.2
Inv. Status
Limited Stock

Synonym :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

34-Hydroxy Sirolimus is chemically . It is also known as Secorapamycin B. 34-Hydroxy Sirolimus is supplied with detailed characterization data compliant with regulatory guideline. 34-Hydroxy Sirolimus can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rapamycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 185107-79-3

Purchase 185107-79-3

Order 185107-79-3

Enquire 185107-79-3

price of 185107-79-3

185107-79-3 Supplier

185107-79-3 Manufacturer

185107-79-3 Exporter

buy high quality 34-Hydroxy Sirolimus

Purchase 34-Hydroxy Sirolimus

34-Hydroxy Sirolimus suppliers

34-Hydroxy Sirolimus manufacturers

34-Hydroxy Sirolimus price

Order 34-Hydroxy Sirolimus

Enquire 34-Hydroxy Sirolimus

34-Hydroxy Sirolimus cost

34-Hydroxy Sirolimus Supplier

34-Hydroxy Sirolimus Distributor

34-Hydroxy Sirolimus for Method Validation

Rapamycin Reference Standard

34-Hydroxy Sirolimus for ANDA Filing

34-Hydroxy Sirolimus for Forced Degradation Studies

34-Hydroxy Sirolimus Identification Standards

34-Hydroxy Sirolimus for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,